BeStock  

Cardinal Health CAH

$272.81 +$0.47 (+0.17%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $272.81 0.00%
Open$276.52
Prev close$272.34
Day range$271.98 – $277.72
Volume1.98M
Market cap$63.06B
P/E (TTM)35.3
Dividend yield0.75%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership90.5%+0.22 pts vs. prior quarter
Institutions holding1,781-4 vs. prior quarter
Insider trades (recent)26 buys / 24 sellsNet buying
Short interest3.27% of floatDays to cover 4.2 · as of 30 Oct 2026
Short-sale volume share20.2%5-day average of daily volume

Short-sale volume as % of daily volume

8%14%19%25%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.18M (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

−$17.6MSuper+$7.4MBig+$11.6MMid+$74.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 33.6% of shares outstanding.

Largest holders

  • BlackRock11.06%
  • Vanguard Capital Management, LLC7.16%
  • Vanguard Portfolio Management, LLC5.86%
  • State Street Global Advisors5.21%
  • Wellington Management Group4.27%
  • Geode Capital Management, LLC2.79%
  • UBS Asset Management1.72%
  • WCM Investment Management1.78%

By investor type

  • Mutual Fund72.83%
  • Public Company5.15%
  • Hedge Fund4.22%
  • Private Company2.82%
  • Government Pension Fund2.60%
  • Sovereign Wealth Fund1.70%
  • Family Office/Trust0.33%
  • Insurance Company0.28%

Reported short interest has risen from 2.75% to 3.27% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Qube Research & Technologies Ltd Mutual Fund 2026/Q4 +1,588,280 0.7%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q4 +1,584,183 0.9%
UBS Asset Management Mutual Fund 2026/Q4 +821,958 1.7%
Millennium Management LLC Hedge Fund 2026/Q4 +747,228 0.4%
Victory Capital Management Inc. Mutual Fund 2026/Q4 +503,549 1.1%
JPMorgan Chase & Co. Public Company 2026/Q4 +491,931 0.7%
Morgan Stanley Public Company 2026/Q4 +450,052 1.4%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q4 +412,818 0.7%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q4 +405,813 0.7%
Los Angeles Capital Management LLC Mutual Fund 2026/Q4 +329,591 0.2%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q4 +322,504 0.4%
Australian Super Government Pension Fund 2026/Q4 +305,073 0.1%
BNP Paribas Financial Markets SNC Private Company 2026/Q4 +297,550 1.0%
Squarepoint OPS LLC Hedge Fund 2026/Q4 +293,393 0.2%
Renaissance Technologies Corp. Hedge Fund 2026/Q4 +285,600 0.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
18 Aug 2026 Mary Scherer Senior Vice President Open Market Disposition -2,302 $237.40 2,811
18 Aug 2026 Jason Hollar Chief Executive Officer Open Market Disposition -124,529 $237.88 115,406
17 Aug 2026 Aaron Alt Chief Financial Officer Open Market Disposition -42,000 $237.26 84
17 Aug 2026 Deborah Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Open Market Disposition -7,354 $237.44 77,901
17 Aug 2026 Jessica Mayer Chief Legal & Compliance Officer Open Market Disposition -29,436 $237.31 16,629
17 Aug 2026 Stephen Mason Chief Executive Officer of GMPD segment Open Market Disposition -35,000 $237.26 18,061
17 Aug 2026 Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services Open Market Disposition -11,650 $237.25 10,330
14 Aug 2026 Jason Hollar Chief Executive Officer Sale to Issuer -103,449 $235.17 239,935
14 Aug 2026 Jason Hollar Chief Executive Officer Other Acquisition +30,616 – 75,197
14 Aug 2026 Aaron Alt Chief Financial Officer Sale to Issuer -30,730 $235.17 42,084
14 Aug 2026 Aaron Alt Chief Financial Officer Other Acquisition +8,079 – 20,411
14 Aug 2026 Deborah Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Sale to Issuer -29,759 $235.17 85,255
14 Aug 2026 Deborah Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Other Acquisition +7,314 – 85,255
14 Aug 2026 Jessica Mayer Chief Legal & Compliance Officer Sale to Issuer -25,285 $235.17 46,065
14 Aug 2026 Jessica Mayer Chief Legal & Compliance Officer Other Acquisition +6,378 – 16,447
14 Aug 2026 Stephen Mason Chief Executive Officer of GMPD segment Sale to Issuer -25,289 $235.17 53,061
14 Aug 2026 Stephen Mason Chief Executive Officer of GMPD segment Other Acquisition +5,868 – 53,061
14 Aug 2026 Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services Sale to Issuer -10,031 $235.17 21,980
14 Aug 2026 Michelle Greene Executive VP and Chief Information Officer of Global Technology & Business Services Other Acquisition +2,551 – 21,980
14 Aug 2026 Mary Scherer Senior Vice President Sale to Issuer -1,757 $235.17 5,113

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,577,324 3.3% 4.2
15 Oct 2026 7,678,341 3.3% 5.0
30 Sep 2026 7,369,236 3.2% 3.4
15 Sep 2026 6,668,906 2.9% 4.6
31 Aug 2026 6,713,462 2.9% 4.4
14 Aug 2026 6,393,294 2.7% 2.9

Discussion

No comments yet — be the first to weigh in on CAH.

Sign in to join the discussion.

Scroll to Top